Lebrikizumab

ATC D11AH10 · 11 markets · 17 records

Lebrikizumab 11 markets · 17 records Forms

US 2 records · 1 strengths

GB 2 records · 1 strengths

  • 250 mg/2 mLinjectionEbglyss 250mg/2ml solution for injection pre-filled pensEbglyss 250mg/2ml solution for injection pre-filled syringes also in US·FR·SG

CA 2 records · 1 strengths

AU 2 records · 2 strengths

  • 125 mg/mLinjectionEBGLYSS lebrikizumab 250 mg/2 mL solution for injection autoinjector (pre-filled pen) unknown
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

ES 2 records · 1 strengths

FR 2 records · 1 strengths

  • 250 mg/2 mLinjectionEBGLYSS 250 mg, solution injectable en seringue préremplieEBGLYSS 250 mg, solution injectable en stylo prérempli also in US·GB·SG

SG 1 records · 1 strengths

MX 1 records · 1 strengths

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

TW 1 records · 1 strengths

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名EBGLYSS ×3異可適注射劑 ×1

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

HK 1 records · 1 strengths

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名EBGLYSS SOLUTION FOR INJECTION IN PRE-FILLED PEN 250MG/2ML ×1

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

EU 1 records · 1 strengths

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.